Exercise as medicine: new trial tests HIIT for mental health recovery
NCT ID NCT06338917
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a 28-week program of moderate-to-vigorous physical activity, including high-intensity interval training, can reduce disability and improve thinking in 100 adults with severe mental illness. Participants are outpatients living in the community. The program starts with group HIIT and transitions to individual activity. Results will be compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
moderate-to-vigorous physical activity program (HIIT and VILPA)
What this could lead to
If it works, this could offer a practical, drug-free way to help people with severe mental illness feel better and function more in daily life.
What could go wrong
This is a small, early-stage trial with only 100 participants, so results may not apply to everyone. Exercise programs can be hard to stick with, and benefits may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENTAL HEALTH ISSUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Vic
Vic, Barcelona, 08500, Spain